Cubist Systematic Strategies’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,990
| Closed | -$197K | – | 1440 |
|
|
2024
Q4 | $197K | Buy |
11,990
+4,682
| +64% | +$77.1K | ﹤0.01% | 1182 |
|
|
2024
Q3 | $181K | Sell |
7,308
-3,970
| -35% | -$98.1K | ﹤0.01% | 1164 |
|
|
2024
Q2 | $286K | Sell |
11,278
-11,420
| -50% | -$289K | ﹤0.01% | 1039 |
|
|
2024
Q1 | $577K | Sell |
22,698
-16,820
| -43% | -$427K | ﹤0.01% | 1342 |
|
|
2023
Q4 | $895K | Sell |
39,518
-38,294
| -49% | -$868K | 0.01% | 1155 |
|
|
2023
Q3 | $1.45M | Buy |
+77,812
| New | +$1.45M | 0.01% | 900 |
|
|
2022
Q4 | – | Sell |
-10,900
| Closed | -$259K | – | 3248 |
|
|
2022
Q3 | $259K | Sell |
10,900
-4,281
| -28% | -$102K | ﹤0.01% | 2851 |
|
|
2022
Q2 | $339K | Buy |
+15,181
| New | +$339K | ﹤0.01% | 2854 |
|
|
2022
Q1 | – | Sell |
-4,527
| Closed | -$162K | – | 3512 |
|
|
2021
Q4 | $162K | Buy |
+4,527
| New | +$162K | ﹤0.01% | 3093 |
|
|
2020
Q3 | – | Sell |
-7,783
| Closed | -$294K | – | 2475 |
|
|
2020
Q2 | $294K | Sell |
7,783
-13,152
| -63% | -$497K | 0.01% | 1854 |
|
|
2020
Q1 | $605K | Sell |
20,935
-169
| -0.8% | -$4.88K | 0.02% | 1134 |
|
|
2019
Q4 | $1.09M | Buy |
21,104
+12,425
| +143% | +$644K | 0.02% | 1103 |
|
|
2019
Q3 | $476K | Sell |
8,679
-4,891
| -36% | -$268K | 0.01% | 1310 |
|
|
2019
Q2 | $551K | Buy |
+13,570
| New | +$551K | 0.01% | 1415 |
|
|
2018
Q4 | – | Sell |
-6,267
| Closed | -$264K | – | 2034 |
|
|
2018
Q3 | $264K | Buy |
+6,267
| New | +$264K | 0.01% | 1240 |
|